OPEN END TURBO OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 01:16:40 29/06/2024 am IST | ||
| 0.8 EUR | +14.29% |
|
| Current month | -37.98% | ||
| 1 month | -37.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.8 | +14.29% |
| 27/24/27 | 0.7 | -22.22% |
| 26/24/26 | 0.9 | -5.26% |
| 25/24/25 | 0.95 | -3.06% |
| 24/24/24 | 0.98 | +3.16% |
Delayed Quote Börse Stuttgart
Last update June 29, 2024 at 01:16 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JQ49W2 |
| ISIN | DE000JQ49W24 |
| Date issued | 25/08/2022 |
| Strike | 100.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.77 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.69 € |
|---|---|
| Lowest since issue | 0.42 € |
| Spread | 0.01 € |
| Spread % | 1.27% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.37
USD
Average target price
96.05
USD
Spread / Average Target
+3.99%
- Stock Market
- Certificates
- Certificat
